By contrast, biNV could stimulate CD8+ T cells to generate increased levels of IFN-γ and TNF-α, leading to a higher rate of T cell-mediated cytolysis against 4T1 and CT26 cancer cells (Fig. 3d, g). This evidence concerns the gene CD8A and cancer.